market-improved

U.S. lawmakers blast Mylan CEO over ‘sickening’ EpiPen price hikes

U.S. lawmakers on Wednesday blasted Mylan NV Chief Executive Heather Bresch for sharply increasing prices for the EpiPen emergency allergy treatment at a congressional hearing in which Republicans and Democrats questioned the reasons behind rising U.S. drug costs. The House Committee on Oversight and Government Reform called Bresch to testify in the wake of public outrage over EpiPen, whose list price has risen to $600 for a pair of the devices compared with $100 in 2007. At several points, they cut …

More here:
U.S. lawmakers blast Mylan CEO over ‘sickening’ EpiPen price hikes

market-improved

Fed keeps rates steady, signals one hike by end of year

The U.S. Federal Reserve left interest rates unchanged on Wednesday but strongly signaled it could still tighten monetary policy by the end of this year as the labor market improved further. Fed Chair Janet Yellen, speaking after the central bank's latest policy statement, said U.S. growth was looking stronger and rate increases would be needed to keep the economy from overheating and fueling high inflation.

Originally posted here:
Fed keeps rates steady, signals one hike by end of year